astria therapeutics glp-1 receptor agonist weight management diabetes treatments

astria therapeutics glp-1 receptor agonist weight management diabetes treatments Ultra-long-acting RA improves loss in individuals with and without type 2 GLP-1 Receptor Agonists in the

Name: astria therapeutics glp-1 receptor agonist weight management diabetes treatments Ultra-long-acting RA improves loss in individuals with and without type 2 GLP-1 Receptor Agonists in the
Brand: inmobiliariafranchi.com
SKU: 4380325203
Price: 23.71 USD
Availability: InStock
Rating: 4.2322 (13 reviews)

SKU: 4380325203

4.2

USD23.71 USD43.71

Pay in 4 interest-free payments of $5.93 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 28 - Sep 2

Description

Origin and Structure (Fragment of Human Growth Hormone) AOD-9604 corresponds to amino acids 176191 of the human growth hormone sequence the C-terminal fragment historically associated with fat metabolism in early growth hormone research

GLP-1/GIP assets primarily target obesity and diabetes indications, but are additionally in the late-stage pipeline for a broad scope of indications including chronic heart failure, osteoarthritis and liver fibrosis